Navigation Links
Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Date:6/23/2009

KENILWORTH, N.J., June 23 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Aug. 31, 2009, to shareholders of record at the close of business on August 7, 2009. As of March 31, 2009, there were 1,628,335,093 common shares outstanding.

The Board of Directors today also declared a quarterly dividend of $3.75 per share on the 2007 Mandatory Convertible Preferred Stock. Payment will be made on Aug. 17, 2009, to holders of record at the close of business on Aug. 3, 2009. There are currently 10 million shares of 2007 Mandatory Convertible Preferred Stock outstanding.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, I...in Board: EMDY), a leading,producer and distributo...d,soybean products in China, today announced that ...f US Food & Drink Executive, a quarterly magaz...n the food and beverage industry. , The a...
(Date:12/2/2009)...ewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ...harmaceutical company focused on endocrine therapy...and Drug Administration (FDA) has granted Fast Tra...inhibitor compound, perifosine (KRX-0401), for the.... Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX)...
(Date:12/2/2009)...ist, a leading scientific magazine covering the li...quo;Intelligent” EMCCD camera fourth among t...f 2009. , (PRWEB) Decembe... Photometrics ®, a designer and manufacturer... life sciences, was ranked fourth among The Scient...
(Date:12/1/2009)...Solomon announced that he has joined Carolina Eyec...site at www.DrKerrySolomon.com , which was develo... proven LASIK, lens implant, and cataract surgery ...his substantial contributions to improving vision ...IK Surgeons, which screens LASIK surgeons based up...
Breaking Biology Technology:Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
... Pharmaceuticals,Inc. (Nasdaq: VIAP ), a biotechn...nds for the treatment of cardiovascular disease, a...g on Tuesday, September 16, 2008 at 12:00pm,Easter... Libby, Chief of,Cardiovascular Medicine at the Br...sor of Medicine at Harvard Medical School, will pr...
...Advanced Pest Control, the Houston based pest cont...ce their recent Quality Pro designation, a mark of...pecial designation, awarded by the National Pest M...teps that Advanced Pest Control has taken to ensur... Houston, TX (PRWEB) September 9, 2008 --...
...ternational,Corporation (Nasdaq: PRXL ), a leadin...today updated its forward-looking financial guidan...ng September 30, 2008) and for the,full Fiscal Yea...f the,acquisition of ClinPhone Plc and other facto...man and Chief Executive Officer of PAREXEL,stated,...
Other Biology Technology:VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16 2VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16 3VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16 4Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 2Advanced Pest Control Earns Quality Pro Designation for General Pest Control Services 3PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 4PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors 5
(Date:12/2/2009)...lescents exposed to cigarette smoking scenes in mo...es, and this may be part of the acculturation proc...to new study findings. , "Our study supports an ...lights the global implementation of the World Heal...ntrol, which includes guidelines for countries to ...
(Date:12/2/2009)...free status did not prompt people participating in...cer screening program to pick up their cigarettes ...Cancer Epidemiology, Biomarkers & Prevention , a j...arch. The December issue contains a special focus ...pread concern in the lung screening community that...
(Date:12/2/2009)...ter, and other foods have done more than raise pub...also are quietly fueling a boom in the market for ...ty regulations. That,s the topic of the two-part c...ineering News , (C&EN) ACS, weekly newsmagazine. ,...r Correspondent Marc Reisch point out that food sa...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Biovista Inc Announces Positive Efficacy Results in a Pre Clinical Trial of its BVA 601 Repositioned Drug for Epilepsy 12744 1Biovista Inc Announces Positive Efficacy Results in a Pre Clinical Trial of its BVA 601 Repositioned Drug for Epilepsy 12744 2B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 1B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 2B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 3B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 4The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 1The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 2The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 3
...logy,s version of the director,s cut. In much the ...ether from a single reel of raw footage, a molecul...ingle gene to produce multiple proteins. Now a new...efeller University and the Howard Hughes Medical I...s for the first time how the specific location of ...
...ers at UC Irvine have found that how much detail o...ain portion of the brain is activated to "package"...y sometimes people only recall parts of an experie... all of the details of a similar experience. , ... imaging (fMRI), the scientists were able to view ...
... the soluble factor TGF-beta has been shown to sup...s of breast cancer, high levels of TGF-beta during...th a poor outcome. A study using human breast canc...ber 7 in advance of publication in the January pri... indicates that changes in expression of one compo...
Other Biology News:RNA map provides first comprehensive understanding of alternative splicing 2RNA map provides first comprehensive understanding of alternative splicing 3RNA map provides first comprehensive understanding of alternative splicing 4Memories: It's all in the packaging, scientists say 2
... accessory lessens the expensive task of validatin...ple mass spectrometers. It converts the unprocesse...SD quadrupole mass spectrometers into analog forma...ratory information management (LIMS) systems for p...
...e deliversoluble protein or No Charge to you! , Ne...esults , 24 solubility optimization parameters app... your most insoluble clones ,The new protein Sol...y tools and know-how recently developed at Genlant...
...ls were designed for full-length gene cloning and ...sired cDNA clone. The first PCR analysis is perfor...ontains plasmid DNA from 5,000 clones. Having iden... of the reaction products, the second PCR analysis...
...ls were designed for full-length gene cloning and ...sired cDNA clone. The first PCR analysis is perfor...ontains plasmid DNA from 5,000 clones. Having iden... of the reaction products, the second PCR analysis...
Biology Products: